A Crucial Group of Covid Drugs Has Stopped Working
A key tool in the early pandemic response, monoclonal antibodies are now ineffective against new variants. Immunocompromised patients are especially at risk.
admin
0
0
A key tool in the early pandemic response, monoclonal antibodies are now ineffective against new variants. Immunocompromised patients are especially at risk.
.jpg?#){kind=small}
